Empire one: first-in-human study of a new transcatheter aortic valve system

Supported by Biosensors

Summary

Join this roundtable discussion with Nicola Ryan and José Antonio Baz Alonso as they delve into the Empire One trial outcomes. Learn about the IMPERIA™ delivery system for the ALLEGRA™ heart valve, its unique features, and trial results, including detailed hemodynamic findings. Hear insights on its potential benefits for valve-in-valve procedures, the patient groups it best serves, and its current limitations. Watch now for key updates in transcatheter heart valve innovation!

This interview was filmed at PCR London Valves 2024: see more videos here.